August 24, 2020 at 12:27 AM EDT
Trump touts FDA’s emergency authorization of convalescent plasma as historic breakthrough, however scientists are uncertain
President Trump introduced Sunday that he had helped break by means of a regulatory “logjam” to grant emergency authorization of convalescent plasma to deal with covid-19, a “powerful therapy” that he claimed “had an incredible rate of success,” although his personal scientists are calling for extra research to definitively present it really works.
The announcement, at a information convention the place Trump was flanked by Food and Drug Administration commissioner Stephen Hahn and Health and Human Services Secretary Alex Azar, drew criticism from physicians and scientists, who mentioned their statements misled the general public by overstating the proof behind a remedy that exhibits promise however nonetheless must be rigorously examined.
“I watched this in horror,” mentioned Eric Topol, an influential doctor and scientist and director of the Scripps Research Translational Institute. “These are basically just exploratory analyses that don’t prove anything. It’s just extraordinary to declare this as a breakthrough … All this does is jeopardize ever getting the truth.”
By Carolyn Y. Johnson, Laurie McGinley, Josh Dawsey and Seung Min Kim